...
首页> 外文期刊>Biochemical Pharmacology >Spectroscopic and biochemical characterisation of self-aggregates formed by antitumor drugs of the camptothecin family: their possible role in the unique mode of drug action.
【24h】

Spectroscopic and biochemical characterisation of self-aggregates formed by antitumor drugs of the camptothecin family: their possible role in the unique mode of drug action.

机译:喜树碱家族抗肿瘤药物形成的自聚集体的光谱和生化特征:它们在独特的药物作用方式中的可能作用。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We describe the effect strongly influencing the biological activity of some camptothecin (CPT) drugs, the inhibitors of DNA topoisomerase I (topo I), namely, the formation of J-type aggregates in an aqueous buffer solution. These aggregates were built up under certain dilution conditions of the stock DMSO solutions of 20-S-camptothecin (20(S)CPT), 10,11-methylenedioxy-CPT (10,11-CPT) and 7-ethyl-10-hydroxy-CPT (SN38). The aggregates were found to be stereospecific, not being detectable for the 20(R)-stereoisomer of CPT. They were formed by the stacking interaction between quinoline rings of CPT chromophores with the inverse position of the nitrogen atoms. The aggregates were stable at acidic and neutral pHs, but dissociated at basic pHs. Self-aggregation prevented hydrolysis of the lactone ring at neutral pHs, thus preserving the drugs in a biologically active form. Addition of BSA did not induce either disaggregation or hydrolysis of the lactone ring, whereas the monomeric form of the drugs was shown to undergo rapid conversion to an inactive carboxylate form in the presence of human serum albumin [5]. The drugs did not form the aggregates in the presence of topo I. Moreover, rapid dissociation of the aggregates was observed if a self-aggregated drug solution was added to topo I alone or to the DNA-topo I cleavage assay. Neither DNA alone nor oligonucleotides derived from the sequences of the CPT-enhanced or topo I-induced cleavage sites in SV40 plasmid DNA induces changes in the aggregation state of the drugs. These observations are indicative of interaction between the aggregates and topo I. The aggregates were found to penetrate within the cells with much higher efficiency than a monomeric form of the drugs. Cellular uptake of aggregated and nonaggregated species correlated well with cytotoxic effects produced by the drug. In this manner, CPT's self-aggregation should be regarded as a favourable phenomenon producing species with a more stable biologically active structure of the lactone ring and exhibiting enhanced cellular uptake levels relative to the monomeric forms of medications.
机译:我们描述了强烈影响某些喜树碱(CPT)药物的生物活性的作用,喜树碱(CPT)药物是DNA拓扑异构酶I(拓扑I)的抑制剂,即在缓冲水溶液中形成J型聚集体。这些聚集体是在20-S-喜树碱(20(S)CPT),10,11-亚甲基二氧基-CPT(10,11-CPT)和7-乙基-10-羟基DMSO储备液的一定稀释条件下建立的-CPT(SN38)。发现该聚集体是立体特异性的,对于CPT的20(R)-立体异构体是不可检测的。它们是由CPT发色团的喹啉环与氮原子的反向位置之间的堆积相互作用形成的。聚集体在酸性和中性pH下稳定,但在碱性pH下解离。自聚集可防止内酯在中性pH下水解,从而将药物保留为生物活性形式。添加BSA不会引起内酯环的解聚或水解,而在人血清白蛋白存在的情况下,药物的单体形式会迅速转化为无活性的羧酸盐形式[5]。在存在topo I的情况下,药物不会形成聚集体。此外,如果将自聚集的药物溶液单独添加到topo I或DNA-topo I裂解试验中,则会观察到聚集体的快速解离。单独的DNA或源自SV40质粒DNA中CPT增强或topo I诱导的切割位点序列的寡核苷酸均不会诱导药物聚集状态的改变。这些观察结果表明聚集体和topo I之间的相互作用。发现聚集体以比单体形式的药物高得多的效率穿透细胞。细胞对聚集和非聚集物种的摄取与药物产生的细胞毒性作用密切相关。以这种方式,CPT的自聚集应被认为是有利的现象,其产生具有更稳定的内酯环的生物活性结构并且相对于药物的单体形式表现出增强的细胞摄取水平的物种。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号